ARCHIVES

Program Announcements

This article is from The Cancer Letter archive.

Vol. 27 No. | August 3, 2001

Download PDF Visit The Full Archive

Related Articles

Prime Contract Subcontract Opportunities

January 24, 1975

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

March 12, 1999

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

May 18, 2007

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992

In Brief: Last Two NCAB Choices Named; Hellman Heads ASCO, Sartorelli Named President Of AACR

May 16, 1986